New Delhi: Drug major Sun Pharmaceutical today reported a 4.72 percent decline in its consolidated net profit to Rs 1,471.82 crore for the third quarter ended December 31, 2016.
The company had posted a net profit after taxes, non-controlling interest and share of profit of associates and joint ventures of Rs 1,544.85 crore for the corresponding period of the previous fiscal, Sun Pharmaceutical Industries said in a filing to BSE.
Consolidated total income from operations, however, rose to Rs 7,912.66 crore for the quarter under review, as against Rs 7122.31 crore in the same period a year ago.
Shares of Sun Pharmaceutical Industries were trading at Rs 654.55 per scrip on BSE, down 0.06 per cent from its previous close.
Zee News App: Read latest news of India and world, bollywood news, business updates, cricket scores, etc. Download the Zee news app now to keep up with daily breaking news and live news event coverage.
